Evolution of the gut Amicrobiome during the pathogenesis of smoking-associated Kras-mutant lung cancer

被引:0
|
作者
Treekitkarnmongkol, Warapen [1 ]
Finnicum, Casey [2 ]
Sinjab, Ansam [1 ]
Hassane, Maya [3 ]
Davis, Christel [2 ]
Davies, Gareth E. [2 ]
Hoffman, Kristi L. [4 ]
Fujimoto, Junya [1 ]
McAllister, Florencia [1 ]
Sepesi, Boris [1 ]
Cascone, Tina [1 ]
Jenq, Robert R. [1 ]
Petrosino, Joseph [4 ]
Ehli, Erik [2 ]
Moghaddam, Seyed J. [1 ]
Kadara, Humam [1 ]
机构
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Avera Inst Human Genet, Sioux Falls, SD USA
[3] Amer Univ Beirut, Beirut, Lebanon
[4] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1158/1538-7445.AM2020-3349
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3349
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Metabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer
    Zhang Yang
    Shun-Qing Liang
    Liang Zhao
    Haitang Yang
    Thomas M. Marti
    Balazs Hegedüs
    Yanyun Gao
    Bin Zheng
    Chun Chen
    Wenxiang Wang
    Patrick Dorn
    Gregor J. Kocher
    Ralph A. Schmid
    Ren-Wang Peng
    Journal of Experimental & Clinical Cancer Research, 41
  • [42] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Xiaoqing Luo
    Shunli Peng
    Sijie Ding
    Qin Zeng
    Rong Wang
    Yueyun Ma
    ShiYu Chen
    Yanxia Wang
    Wei Wang
    Cancer Cell International, 21
  • [43] Uncovering mechanisms of immune evasion in a novel immunogenic model of KRAS-mutant lung cancer.
    Boumelha, Jesse
    de Carne, Sophie
    Mugarza, Edurne
    Romero-Clavijo, Pablo
    Molina-Arcas, Miriam
    Downward, Julian
    CANCER RESEARCH, 2021, 81 (13)
  • [44] An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
    Boumelha, Jesse
    Trecesson, Sophie de Carne
    Law, Emily K.
    Romero-Clavijo, Pablo
    Coelho, Matthew A.
    Ng, Kevin W.
    Mugarza, Edurne
    Moore, Christopher
    Rana, Sareena
    Caswell, Deborah R.
    Murillo, Miguel
    Hancock, David C.
    Argyris, Prokopios P.
    Brown, William L.
    Durfee, Cameron
    Larson, Lindsay K.
    Vogel, Rachel, I
    Suarez-Bonnet, Alejandro
    Priestnall, Simon L.
    East, Philip
    Ross, Sarah J.
    Kassiotis, George
    Molina-Arcas, Miriam
    Swanton, Charles
    Harris, Reuben
    Downward, Julian
    CANCER RESEARCH, 2022, 82 (19) : 3435 - 3448
  • [45] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Giorgia Maroni
    Mahmoud A. Bassal
    Indira Krishnan
    Chee Wai Fhu
    Virginia Savova
    Rapolas Zilionis
    Valerie A. Maymi
    Nicole Pandell
    Eva Csizmadia
    Junyan Zhang
    Barbara Storti
    Julio Castaño
    Riccardo Panella
    Jia Li
    Corinne E. Gustafson
    Sam Fox
    Rachel D. Levy
    Claire V. Meyerovitz
    Peter J. Tramontozzi
    Kimberly Vermilya
    Assunta De Rienzo
    Stefania Crucitta
    Daniela S. Bassères
    Marla Weetall
    Art Branstrom
    Alessandra Giorgetti
    Raffaele Ciampi
    Marzia Del Re
    Romano Danesi
    Ranieri Bizzarri
    Henry Yang
    Olivier Kocher
    Allon M. Klein
    Robert S. Welner
    Raphael Bueno
    Maria Cristina Magli
    John G. Clohessy
    Azhar Ali
    Daniel G. Tenen
    Elena Levantini
    Communications Biology, 4
  • [46] Management of KRAS-Mutant Non-Small Cell Lung Cancer in the Era of Precision Medicine
    Aredo, Jacqueline V.
    Padda, Sukhmani K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (08)
  • [47] Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer
    Maroni, Giorgia
    Bassal, Mahmoud A.
    Krishnan, Indira
    Fhu, Chee Wai
    Savova, Virginia
    Zilionis, Rapolas
    Maymi, Valerie A.
    Pandell, Nicole
    Csizmadia, Eva
    Zhang, Junyan
    Storti, Barbara
    Castano, Julio
    Panella, Riccardo
    Li, Jia
    Gustafson, Corinne E.
    Fox, Sam
    Levy, Rachel D.
    Meyerovitz, Claire, V
    Tramontozzi, Peter J.
    Vermilya, Kimberly
    De Rienzo, Assunta
    Crucitta, Stefania
    Basseres, Daniela S.
    Weetall, Marla
    Branstrom, Art
    Giorgetti, Alessandra
    Ciampi, Raffaele
    Del Re, Marzia
    Danesi, Romano
    Bizzarri, Ranieri
    Yang, Henry
    Kocher, Olivier
    Klein, Allon M.
    Welner, Robert S.
    Bueno, Raphael
    Magli, Maria Cristina
    Clohessy, John G.
    Ali, Azhar
    Tenen, Daniel G.
    Levantini, Elena
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [48] Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
    Caterina Bartolacci
    Cristina Andreani
    Gonçalo Vale
    Stefano Berto
    Margherita Melegari
    Anna Colleen Crouch
    Dodge L. Baluya
    George Kemble
    Kurt Hodges
    Jacqueline Starrett
    Katerina Politi
    Sandra L. Starnes
    Daniele Lorenzini
    Maria Gabriela Raso
    Luisa M. Solis Soto
    Carmen Behrens
    Humam Kadara
    Boning Gao
    Ignacio I. Wistuba
    John D. Minna
    Jeffrey G. McDonald
    Pier Paolo Scaglioni
    Nature Communications, 13
  • [49] XPO1-dependent nuclear export is a druggable vulnerability in KRAS-mutant lung cancer
    Kim, Jimi
    McMillan, Elizabeth
    Kim, Hyun Seok
    Venkateswaran, Niranjan
    Makkar, Gurbani
    Rodriguez-Canales, Jaime
    Villalobos, Pamela
    Neggers, Jasper Edgar
    Mendiratta, Saurabh
    Wei, Shuguang
    Landesman, Yosef
    Senapedis, William
    Baloglu, Erkan
    Chow, Chi-Wan B.
    Frink, Robin E.
    Gao, Boning
    Roth, Michael
    Minna, John D.
    Daelemans, Dirk
    Wistuba, Ignacio I.
    Posner, Bruce A.
    Scaglioni, Pier Paolo
    White, Michael A.
    NATURE, 2016, 538 (7623) : 114 - +
  • [50] Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer
    Luo, Xiaoqing
    Peng, Shunli
    Ding, Sijie
    Zeng, Qin
    Wang, Rong
    Ma, Yueyun
    Chen, ShiYu
    Wang, Yanxia
    Wang, Wei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)